Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-04-25 8:01 pm Sale | 13G | CELLECTAR BIOSCIENCES INC CLRB | Rosalind Advisors Inc. | 3,992,586 9.9% | -2,684,347 (-40.20%) | View |
| 2024-04-25 7:39 pm Sale | 13G | Trevi Therapeutics Inc. TRVI | Rosalind Advisors Inc. | 926,016 1.34% | -1,573,977 (-62.96%) | View |
| 2024-04-25 7:30 pm Unchanged | 13G | INSPIREMD INC NSPR | Rosalind Advisors Inc. | 8,988,318 9.9% | 0 (Unchanged) | View |
| 2024-04-25 7:22 pm Purchase | 13G | MediWound Ltd. MDWD | Rosalind Advisors Inc. | 485,990 6.92% | 6,000 (+1.25%) | View |
| 2024-04-25 7:13 pm Unchanged | 13G | MYOMO INC. MYO | Rosalind Advisors Inc. | 4,575,385 9.9% | 0 (Unchanged) | View |
| 2024-04-25 7:01 pm Sale | 13G | OPTINOSE INC OPTN | Rosalind Advisors Inc. | 4,541,489 5.14% | -344,091 (-7.04%) | View |
| 2024-04-25 6:52 pm Sale | 13G | SPRUCE BIOSCIENCES INC SPRB | Rosalind Advisors Inc. | 1,508,419 3.67% | -813,581 (-35.04%) | View |
| 2024-03-25 6:55 pm Purchase | 13D | DELCATH SYS INC DCTH | Rosalind Advisors Inc. | 2,952,202 9.9% | 541,678 (+22.47%) | View |
| 2024-03-21 09:05 am Unchanged | 13G | BIOFRONTERA INC BFRI | Rosalind Advisors Inc. | 504,261 9.9% | 0 (Unchanged) | View |
| 2024-03-20 9:21 pm Purchase | 13G | BIOFRONTERA INC BFRI | Rosalind Advisors Inc. | 504,261 9.9% | 504,261 (New Position) | View |
| 2024-03-01 12:19 pm Purchase | 13G | PolyPid Ltd. PYPD | Rosalind Advisors Inc. | 415,800 9.95% | 415,800 (New Position) | View |
| 2024-02-22 4:28 pm Sale | 13G | OPTINOSE INC OPTN | Rosalind Advisors Inc. | 4,885,580 4.4% | -1,549,420 (-24.08%) | View |
| 2024-02-20 1:42 pm Sale | 13G | GUIDED THERAPEUTICS INC GTHP | Rosalind Advisors Inc. | 0 0% | -2,338,740 (Position Closed) | View |
| 2024-02-20 1:38 pm Sale | 13G | SIENTRA INC SIENQ | Rosalind Advisors Inc. | 0 0% | -509,274 (Position Closed) | View |
| 2024-02-15 10:42 am Unchanged | 13G | MYOMO INC. MYO | Rosalind Advisors Inc. | 4,575,385 9.2% | 0 (Unchanged) | View |
| 2024-02-14 9:40 pm Sale | 13G | MYOMO INC. MYO | Rosalind Advisors Inc. | 4,575,385 9.2% | -2,757,949 (-37.61%) | View |
| 2024-02-14 9:33 pm Unchanged | 13G | INSPIREMD INC NSPR | Rosalind Advisors Inc. | 8,988,318 9.9% | 0 (Unchanged) | View |
| 2024-02-14 8:48 pm Unchanged | 13G | OPTINOSE INC OPTN | Rosalind Advisors Inc. | 479,990 5.2% | 0 (Unchanged) | View |
| 2024-02-14 8:43 pm Purchase | 13G | MediWound Ltd. MDWD | Rosalind Advisors Inc. | 479,990 5.2% | 35,664 (+8.03%) | View |
| 2024-02-14 8:31 pm Purchase | 13G | CELLECTAR BIOSCIENCES INC CLRB | Rosalind Advisors Inc. | 6,676,933 9.9% | 4,518,661 (+209.36%) | View |